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Abstract  24 
Although recent years have seen large decreases in the overall global rate of suicide fatalities, this trend is not reflected 25 
everywhere. Suicide and suicidal behaviour continue to present key challenges for public policy and health services, with 26 
increasing suicide deaths in some countries, such as the USA. The development of suicide risk is complex, involving 27 
contributions from biological (including genetics), psychological (such as certain personality traits), clinical (comorbid 28 
psychiatric illness), social and environmental factors. The involvement of multiple risk factors in conveying risk of suicide 29 
means that determining an individual’s risk of suicide is challenging. Improving risk assessment, for example using 30 
computer testing and genetic  screening, is an area of ongoing research. Prevention is key to reduce the number of 31 
suicide deaths, and current efforts include universal, selective and indicated interventions, although these interventions 32 
are often delivered in combination. These interventions, combined with psychological (such as cognitive behavioural 33 
therapy, caring contacts and safety planning) and pharmacological treatments (for example, clozapine and ketamine) 34 
and coordinated social and public health initiatives, should continue to improve the management of suicidal patients 35 
and decrease suicide-associated morbidity. 36 
 37 
[H1] Introduction  38 
Although suicide is not a disease, suicidal behaviour, which includes suicide and suicide attempts, is an important public 39 
health problem and has been the focus of increasing attention in research and public awareness campaigns over the 40 
past decade, as well as a major focus of the international public health community1. Despite a one-third reduction in the 41 
global suicide rate, suicide deaths remain frequent across the globe1,2. Each suicide death represents an individual 42 
tragedy and is estimated to indirectly affect many individuals, including family, friends and communities3. 43 
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 44 
Advances in our understanding of the various factors involved in suicide risk have enabled us to paint a more 45 
comprehensive picture of suicidal behaviour. Although the literature base on suicidal behaviour has been growing, its 46 
interpretation and integration is at times complicated by the multiple phenotypes that may be considered across the 47 
suicide spectrum. These phenotypes include suicidal ideation, which is defined as thoughts about ending one’s own life 48 
(whether active (with a plan) or passive (with only a wish to die but no plan)), suicide attempt and death by suicide (Box 49 
1). The risk of acting on suicidal thoughts increases with the frequency, intent and content (such as presence of a plan, 50 
levels of ambivalence or hopelessness, among others) of suicidal ideation. A suicide attempt is defined as self-injurious 51 
behaviour with inferred or actual intent to die. Although detailed nomenclatures have been proposed for the 52 
terminology related to suicide4,5, they have not been widely adopted and diverse terms are still frequently used to 53 
describe similar phenomena. As a consequence, this Primer uses terms that are most consistent with the accepted 54 
nomenclature (Box 1).  55 
Although suicidal ideation occurs in depressive states across different psychopathologies, the transition from suicidal 56 
ideation to a suicide attempt is facilitated by co-occurring psychiatric conditions that increase distress (such as panic 57 
disorder or post-traumatic stress disorder) or decrease restraint (such as substance abuse or cluster B personality 58 
disorders)6. Additional factors that are involved in this transition have been identified, such as capability for suicide, 59 
exposure to suicide, mental imagery and access to the means of suicide7-10. In contrast to suicide attempts, non-suicidal 60 
self-injury most commonly involves self-cutting to relieve negative affect without suicidal intent and is classified 61 
separately from suicidal behaviour by North American clinicians. In Europe, non-suicidal self-injury is sometimes 62 
classified with suicide attempts under the term self-harm because the risk factors for the two types of behaviour overlap 63 
and they commonly co-occur11. 64 
Strategies for preventing suicide have been implemented in most countries, with varying degrees of success. Prevention 65 
strategies are typically grouped under universal (population-wide) strategies, selective strategies (targeting sub-66 
populations or environments within the larger population that could be at increased risk) or indicated strategies (in at-67 
risk individuals who have already exhibited some form of suicidal behaviour or ideation). For these individuals, 68 
treatment strategies relying on psychotherapy or pharmacotherapy may also be indicated alone or in combination, 69 
depending on the characteristics of the individual. 70 
This Primer discusses the epidemiology and global burden of suicide and suicidal behaviours, in addition to providing an 71 
overview of our current understanding of the mechanisms of suicide, including risk factors for suicidal ideation and the 72 
transition from ideation to suicide attempt. In addition, this Primer describes the prevention and treatment of suicide, 73 
and quality of life issues faced by people with suicidal behaviours. 74 
[H1] Epidemiology  75 
Based on self-report survey data, the WHO has estimated that for every death by suicide ~20 people make suicide 76 
attempts1. This ratio varies from country to country depending on the lethality of commonly used suicide methods. In all 77 
countries, the incidence of suicide attempts is highest in individuals 15–24 years of age. By comparison, the lowest rates 78 
of suicide is observed amongst young people <15 years of age, with the highest generally observed in people >75 years 79 
of age1. However, the age-groups with the highest incidence at other ages vary from region to region; for example, in a 80 
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number of high-income countries (such as the USA and UK) a second peak occurs amongst middle-aged men and women 81 
(45–60 years of age)1. Rates of suicide attempt are generally higher in females than in males12, as is the prevalence of 82 
anxiety and depression13. However, in most countries, the rates of suicide are 2–3 times higher in males than in 83 
females1, which could possibly be due to a male preference for higher lethality methods, and the reluctance of males to 84 
seek help 1 (Figure 1). Suicidal ideations are considerably more frequent than suicidal behaviour, but incidence estimates 85 
vary depending on the definitions and wording used in the study — these definitions can range from thoughts that life is 86 
not worth living to making concrete plans to end one’s life. For example, in an analysis of World Mental Health Survey 87 
data from 17 countries, the reported lifetime prevalence of suicidal ideation was 9.2%, with a lifetime prevalence of 88 
suicidal plans of 3.1%12. A person’s willingness to report suicidal ideation and attempts may also depend on their 89 
religious beliefs, stigma and the methods used for collecting data (such as self-report questionnaire, interview 90 
administered survey or hospital admission data).  91 
 92 
[H2] Geographic variations in incidence  93 
The incidence of suicide varies more than ten-fold between countries (Figure 2); incidence is relatively low in the Middle 94 
East and some South and Central American countries, and high in Eastern Europe, Russia, India and South Korea. Of 95 
note, the vast majority of global suicides and suicide attempts occur in low-income and middle-income countries, where 96 
treatment options are limited1. Several factors are believed to account for these differences in suicide rates, such as 97 
variations in the accuracy of suicide statistics. Indeed, several factors can affect the reporting of suicide, such as 98 
inconsistent recording of suicides by coroners and cultural or religious acceptability of suicide. To this end, cultural 99 
factors (as well as possible genetic factors) might have a role, as a number of studies have shown that the between-100 
country ranking of national suicide rates is maintained amongst first-generation migrants to a single country operating a 101 
consistent suicide recording process14. In addition, the availability and cultural preferences for high-lethality suicide 102 
methods can influence between-country suicide rates. For example, poisons commonly ingested in high-income 103 
countries, such as analgesics and psychotropic medications, are generally considerably less toxic than pesticides, which 104 
are commonly used in suicide attempts in many low-income countries15. Indeed, pesticides such as paraquat that have a 105 
case fatality rate of >50% are readily available in low-income countries in which many people are involved in subsistence 106 
farming — pesticide ingestion accounts for approximately one-fifth of global suicides16. Moreover, variations in the 107 
acceptability of suicide because of religious sanctions against suicidal behaviour (such as in predominantly Catholic or 108 
Muslim countries), and variations in levels of alcohol and drug misuse could contribute to the global differences in 109 
suicide rates. In terms of the latter point, high levels of alcohol misuse may account for the high incidence of suicide in 110 
Eastern Europe17. The effects of these various risk factors likely overlap and may be confounded by relative levels of 111 
prosperity and ethnic and religious diversity within individual countries. 112 
As well as global differences in suicide rates, several studies have reported marked (that is, 2–5 fold) variations in suicide 113 
rates within countries. For instance, one analysis of suicide in Taipei (Taiwan) documented 5-fold variations in the 114 
incidence of suicide between areas18. In this study, the factor most strongly associated with area differences was 115 
average levels of household income18. 116 
 [H2] Temporal trends  117 
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As mentioned above, the WHO estimates that there are ~785,000 suicides annually around the world, with an incidence 118 
of 10.6 per 100,000 population in 2016 (Ref19). Global suicide rates have fallen by ~30% in the 21st century2, which has 119 
largely been driven by marked falls in China and, to a lesser extent, India2. This overall trend has masked increases in 120 
other countries, such as the USA and Brazil, where rates rose by 35% between 2000 and 201619 (Figure 3). Explanations 121 
for these differing trends are unclear. Economic growth in China has been accompanied with reductions in suicide rates, 122 
whereas the opposite has been observed in South Korea, which experienced a 130% rise in suicide between 2000 and 123 
2010, although its rate has declined somewhat in recent years19.  124 
In addition to geographical differences, time trends in suicide rates vary in different age groups. In addition to 125 
geographic differences, time trends in suicide rates vary in different age groups. For example, in recent years suicide 126 
rates have fallen in elderly men but risen in middle-aged men and women in the UK20,21. In China, suicide rates are falling 127 
in almost all age groups22, whereas in India they are falling in young people but rising in the elderly23. 128 
In general, key influences on secular trends in suicide include periods of economic recession (which are generally 129 
associated with increases24,25), changes in access to commonly used, high-lethality suicide methods26,27, periods of war 130 
(which are generally associated with falls in suicide) and media reporting of celebrity suicides (which may lead to 131 
transient increases in suicide rates28). 132 
 133 
[H1] Mechanisms/pathophysiology 134 
Risk of suicide is influenced by the interaction of a variety of biological, clinical, psychological, social, cultural and 135 
environmental factors. General models to understand suicide risk have been proposed9,10, and most models recognize 136 
that suicide risk is a result of the interplay between predisposing (also known as distal or diathesis) and precipitating 137 
(also known as proximal, triggering or stress) factors, with some models also specifying a role for developmental factors. 138 
One such example is the biopsychosocial model for suicide (Figure 4)6,29,30, which describes the interactions of genetic, 139 
experiential, psychological, clinical, sociological and environmental factors in the development of suicide risk. Although 140 
any number of these factors might be involved, their relative association with suicide risk varies greatly between 141 
individuals and can be mediated by a variety of factors, such as anxious or impulsive personality traits31,32, and having 142 
social support and stable relationships, which lead to the aetiological heterogeneity of suicide and suicidal behaviour. 143 
The relative importance of these diverse factors also varies by age and sex33. This model is compatible with the multiple 144 
phenotypes along the suicide spectrum that are observed in practice, as described above. In the following sections, risk 145 
factors are classified as distal, developmental and proximal according to their temporal relationship to suicide. Although 146 
this classification is helpful to understand relationships between risk factors and to build a model of suicide risk, it is 147 
imperfect as some risk factors, such a socioeconomic status or genetic and epigenetic factors, can act simultaneously in 148 
different categories. 149 
[H2] Distal or predisposing factors 150 
[H3] Familial and genetic predisposition. Suicidal behaviour has been known to cluster in families for >30 years, but 151 
convincing evidence for the heritability of suicidal behaviour has been provided only in the past decade from large 152 
cohort studies, including evidence that suicide and suicide attempts are transmitted independently of 153 
psychopathologies31,32,34,35. National registry-based studies, twin and adoption studies all suggest a heritability of 30–154 
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50%36,37, although a more accurate estimate may be 17–36% once the heritability of comorbid psychiatric disorders is 155 
controlled for37. In addition, the offspring of individuals who have attempted suicide have a 5-fold greater risk of 156 
attempting suicide than the general population38, and suicide risk is doubled among individuals who lost a parent to 157 
suicide compared with those who lost a parent suddenly due to other causes, although <5% of people who take their 158 
own life have a history of parental suicide39. These data showing the familial clustering of suicidal behaviour further 159 
support the concept of genetic transmission. However, despite intensive investigations over the past 20 years, no single 160 
gene or group of genes has been identified as responsible for suicidal ideation, suicide attempt, or suicide across 161 
multiple studies30. 162 
Suicide deaths are a rare event and, therefore, genome-wide studies (GWAS) generally investigate non-fatal suicidal 163 
behaviour; the findings of GWAS have been compiled and published elsewhere30,40. Of note, only a handful of GWAS 164 
have included suicide as a primary phenotype40-42. These studies identified a total of 32 single nucleotide polymorphisms 165 
(SNPs) of interest, of which multiple SNPs were associated with the TBX20 locus41,42. The gene product of TBX20 has 166 
been implicated in the central nervous system, although its specific roles are unknown41. Although these findings need 167 
replication, one study that used exome sequencing of brain tissue from individuals who died by suicide has identified a 168 
number of candidate gene variants associated with suicide, such as of COL6A6 (encoding the alpha 6 chain of collagen 169 
type VI, which is involved in axon guidance), GNAL (associated with schizophrenia), BACE1 (potentially associated with 170 
Alzheimer’s disease), NREP (associated with neural regeneration) and CDC34 (a ubiquitin-conjugating enzyme involved in 171 
cell cycle control)43. Other studies using suicide attempt and suicidal ideation as primary phenotypes identified multiple 172 
SNPs of interest that were associated with genes involved in several biological processes including, among others, 173 
nervous system development and function, immunological disease, infectious disease and the inflammatory response41.  174 
Despite a few reports confirming associations between genes identified in GWAS and suicide phenotypes, overall, 175 
candidate-gene-based studies44,45 and GWAS30,40,46-49 have not produced consistent results, with genes of interest 176 
frequently failing to pass rigorous reproducibility and significance testing. Similar to other behavioural phenotypes, 177 
individual genetic variants contribute only a small portion of the total variation in the suicidal behaviour phenotype, and 178 
despite the relatively large samples used in GWAS, they often lack appropriate power to detect significant loci and 179 
replicate previous findings50. Efforts to describe the association between genetic variance and suicidal behaviour using 180 
polygenic approaches have yielded promising results50,51. 181 
[H3] Early-life adversity. The past decade has seen great advances in our understanding of the ways that experiences 182 
can be translated into altered gene expression through epigenetic mechanisms52,53. Although changes to gene 183 
expression in response to environmental cues are essential in neurodevelopment, negative social experiences during 184 
critical periods of development can also lead to altered gene expression that is believed to contribute to 185 
psychopathology. Indeed, early life adversity (ELA), defined as neglect or physical or sexual abuse during childhood, is 186 
strongly associated with suicidal behaviour later in life54,55,29. Evidence for this association comes from several 187 
observational studies55-57, and has since been investigated by studying the biological imprinting of these negative early-188 
life traumatic experiences through epigenetic changes, including DNA methylation and histone modifications58-60 (see 189 
Stress response and the hypothalamic–pituitary–adrenal (HPA) axis, below). 190 
[H2] Developmental factors  191 
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Although distal factors are important contributors to suicide risk, their link with suicidal behaviour is at least partially 192 
mediated by other factors . Such developmental or mediating factors, which may result in part from predisposing 193 
factors, increase vulnerability to maladaptive responses to proximal factors, thereby increasing the risk of suicidal 194 
ideation or suicidal behaviour. Of note, behavioural changes are regulated by biological processes61, although these 195 
processes are often poorly understood. 196 
[H3] Personality traits associated with suicidal ideation and suicidal behaviour. Key mediating factors between distal 197 
factors and proximal (also known as precipitating) factors include personality traits62. Among these, those most robustly 198 
associated with suicidal behaviour are anxiety and impulsive-aggressive traits (for example, the latter are those traits 199 
that are associated with externalizing disorders like attention-deficit/hyperactivity disorder, borderline personality 200 
disorder, oppositional defiant disorder and conduct disorder)32,57,63. Longitudinal trajectory studies have provided 201 
convincing evidence linking behavioural traits with long-term suicidal behaviour57,64. Although multiple studies have 202 
found an association between both childhood anxiety and stable anxiety in adulthood with suicidal behaviour 65,66, when 203 
anxiety is considered as an independent variable for statistical analyses, some studies have reported only a weak or non-204 
significant link with suicidal behaviour66,67. Anxiety is likely to contribute to suicidal behaviour by interacting with other 205 
characteristics of individuals who already have increased vulnerability to suicide. For example, in trajectory studies 206 
accounting for ELA, anxiety convincingly explained the link between ELA and suicidal behaviour later in life68, and some 207 
evidence suggests a stronger link between anxiety and suicidal behaviour in girls than in boys63. In studies examining the 208 
familial transmission of suicidal behaviour the transmission of impulsive-aggressive traits has at least partially explained 209 
familial aggregation of suicidal behaviour 31,34,38. Indeed, relatives of individuals who died by suicide are more likely to 210 
have increased impulsivity and aggression, and have an increased risk of suicidal behaviour compared to individuals 211 
without first-degree relatves who died by suicide32,35. The familial transmission of behavioural traits is likely explained by 212 
both genetics69 and by lived experiences, as growing evidence has implicated epigenetic mechanisms in the regulation of 213 
aggression in adults70,71. The socially prescribed aspects of perfectionism (real or perceived social expectations of 214 
performance) are also associated with suicidal ideation and suicide attempts in clinical and population samples72, and 215 
likely increase individual sensitivity to social rejection, defeat and entrapment9. The analysis of population samples 216 
might provide a relevant clinical perspective on the contributions of personality traits associated with suicide risk73, 217 
including negative affect, which is a tendency to have negative emotions, such as to have low self-esteem.  218 
[H3] Link between ELA and personality traits. As discussed above, ELA is strongly associated with suicidal behaviour and 219 
is associated with stable epigenetic changes. In animal models of ELA, negative experiences during post-natal 220 
development lead to behavioural changes in adulthood, such as fearfulness74 or aggression75. Subsequent work also 221 
linked altered behaviour in ELA models to lasting epigenetic changes in stress regulation pathways (see Stress response 222 
and the HPA axis, below)76. In addition, individuals who have experienced ELA have a greater risk of developing 223 
pathological traits and emotional dysregulation, including both internalizing and externalizing behaviours, altered brain 224 
structure and impaired executive function77 all of which are traits that overlap with the suicidal phenotype57 ,78. 225 
[H3] Cognitive deficits. Diminished problem-solving ability, impaired memory and decreased positive future thinking 226 
have been associated with suicidal behaviour79. Additionally, hyperactive cortisol response to stress (see Stress response 227 
and the HPA axis, below), suicidal behaviour, or having a first-degree relative with suicidal behaviour have all been 228 
associated with decreased cognitive function in stressful situations, suggesting that cognitive impairments associate with 229 
risk factors for suicide80,81, and individuals with poor problem-solving skills are more likely to exp4erience suicidal 230 
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ideation in response to stress82. In addition, a five-fold increased risk of suicide attempts has been reported between 231 
high-achieving and low-achieving students in cohort studies, highlighting the importance of IQ and school performance 232 
in influencing suicide risk83. 233 
Cognitive deficits are also more frequent among individuals with experiences of ELA84.This association is likely due to the 234 
interaction between ELA and the still-developing brain throughout youth and young adulthood85, which can lead to 235 
neuroanatomical and functional changes30 . Together, these lines of evidence support a role for cognitive deficits as 236 
mediating risk factors for suicidal behaviour.  237 
[H2] Proximal or precipitating factors 238 
Beyond the factors that confer risk to suicidal behaviour, either distally to the suicidal episode or through development 239 
of traits associated with suicidal ideation and suicidal behaviour, there are identifiable factors that proximally associate 240 
with suicidal behaviour and that are commonly regarded as precipitating or facilitating it. Nonfatal suicidal behaviour is 241 
among the most robust predictors of future suicidal behaviour and suicide death. Indeed, ~40% of people dying by 242 
suicide have previously attempted suicide, and long-term follow-up studies have indicated that the risk of suicide 243 
amongst people who survived a suicide attempt is 1.6% within 12 months86 and ~4% at 5 years87. Despite these data, it is 244 
important to note that the vast majority of individuals who experience suicidal ideation or attempt suicide do not 245 
ultimately die by suicide, and certain risk factors might help to distinguish the likelihood of suicide attempt. In addition, 246 
some clinical factors that may influence the transition from suicidal ideation to suicide attempt include anxiety 247 
disorders, impulse-control disorders, post-traumatic stress disorder, eating disorders, previous self-harm, exposure to 248 
suicidal behaviour in others, and alcohol and drug abuse or dependence6,7,88. Additionally, epidemiological evidence 249 
supports a role for disorders that decrease restraint (such as substance abuse, oppositional defiant disorder and 250 
obsessive-compulsive disorder) or increase distress (panic disorder and post-traumatic stress disorder) in increasing the 251 
likelihood of a transition from suicidal ideation to suicide attempt, particularly in the context of mood disorders86. 252 
However, currently, it is not yet clear how to distinguish between individuals who may experience suicidal ideation but 253 
never progress to suicidal behaviour, from those who may have one or multiple suicide attempts or who ultimately die 254 
by suicide. 255 
[H3] Psychiatric disorders associated with suicide. Mental illness is a key antecedent to suicide. Indeed, estimates of the 256 
proportion of people experiencing a mental illness at the time of their suicide range from ~ 90% in North America to 30–257 
70% in east Asia89-92, with individual reports citing rates as low as 7% in some countries93. These disorders can be 258 
detected through retrospective interviews with family and friends of the deceased using psychological autopsy methods; 259 
however, they are not always diagnosed or treated before death, and likely represent one of the key modifiable aspects 260 
of an individual’s suicide risk. Surprisingly, even in countries with accessible, free-at-the-point-of-use, mental health 261 
services such as the UK, only ~25% of people dying by suicide are in current or recent contact with mental health 262 
services94.  263 
The most common psychiatric diagnoses in people who die by suicide are major depressive disorder (MDD), bipolar 264 
disorder, substance use disorders and schizophrenia89. Although suicide is not an inevitable outcome of any psychiatric 265 
disease, specific features of individual diseases are associated with suicide, such as certain demographics and the 266 
individual’s insight into their illness in schizophrenia95; early-stage illness, mixed-state episodes and irritable dysphoric 267 
states for bipolar disorder96; number, duration and intensity of episodes for MDD97,98. It is likely that the co-occurrence 268 
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of depressive symptoms and other factors that inhibit behavioural control may contribute to suicidal behaviour. In 269 
addition, one cross-national study has demonstrated that disorders characterized by anxiety and poor impulse control 270 
are strongly associated with the transition from suicidal ideation to a suicide attempt88, and one birth cohort study has 271 
identified substance use and personality traits as strong correlates of suicide attempt, in both those who did or did not 272 
have previous suicidal ideation, with higher intellect/openness as a factor in those with suicidal ideation and lower 273 
extraversion as a factor in those without suicidal ideation7. 274 
Substance use or misuse is found in a large proportion of people who died by suicide89, with alcohol misuse in up to 40% 275 
and use of illicit substances in up to 25%99. In individuals who die by suicide, those with multiple predisposing factors 276 
(considered to have high-risk histories) tend to show higher rates of substance disorders at the time of death100,101. 277 
Although the association of suicidal behaviour with alcohol use has been more extensively studied than with other 278 
substances, there are indications that in addition to the use of alcohol, recent (within 6 months) use of sedative-279 
hypnotic drugs and cannabis are more frequently associated with suicide attempt than other substances102,103. 280 
Impulsivity is likely to be a key mediator of substance use associated with suicidal ideation and suicidal behaviour99. 281 
Indeed, individuals with high impulsivity are more likely to use substances, and individuals with alcohol use disorder at 282 
the time of their suicide are more likely to also have high levels of impulsive-aggressive behaviour than those without 283 
alcohol use disorder at the time of suicide104. However, identifying causality is complex as animal studies have indicated 284 
that chronic substance use may drive increased impulsivity105, and human studies have suggested that the pattern of 285 
consumption may equally be important, with binge use of both legal and illegal substances being more closely 286 
associated with suicide attempt than non-bingeing substance use103,106.  287 
In addition, ample evidence supports the contributions of concurrent physical and mental illness (such as central 288 
nervous system and psychiatric disorders, inflammatory diseases, chronic obstructive pulmonary disorder and pain) to 289 
suicide risk107,108. Although impulsive-aggressive traits, substance abuse and conduct disorder make proportionally larger 290 
contributions to suicide risk in younger people7,97,109, depression, physical comorbidity, sleep and pain issues, and 291 
cognitive impairment are substantial contributors to suicidal behaviour in older people110,111. In terms of sleep problems, 292 
decreased sleep time, insomnia, and nightmares have been related to risk for suicidal behaviour112. Chronic pain is also a 293 
predictor of suicide and suicidal behaviour, both independently, as well as via co-occurring difficulties of disability, sleep 294 
problems, reduced well-being and depression113. 295 
[H3] Psychological factors that contribute to suicide. From a psychological point of view, one of the key drivers of 296 
suicidal ideation and suicidal behaviour is the concept of unbearable psychological pain. Initial attempts to understand 297 
the components of psychological pain and their relationship with suicide attempt initially focused on a perceived lack of 298 
belonging, being an increased burden on others, and acquired capability (that is, the ability to engage in suicidal 299 
behaviours)10,114. More recent efforts have identified a wider range of components, such as hopelessness and knowledge 300 
of or comfort with lethal means, and this approach has evolved to more specifically distinguish between factors that are 301 
associated with suicidal ideation and those that are associated with subsequent suicide attempt8,9,115,116. Indeed, the 302 
importance of other mediating factors, that, together with psychological pain, associate with subsequent suicidal 303 
ideation and suicidal behaviour is increasingly acknowledged; these factors include psychological and cognitive traits 304 
(such as impaired problem-solving and memory biases and rumination), as well as proximally-acting factors (such as 305 
feelings of defeat and entrapment, impulsivity, intentions/planning, implementation of a plan, access to means and 306 
imitation/exposure to suicidal behaviour of others). Of particular interest is work using population-cohorts, in which 307 
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volitional phase factors9 (such as acquired capability, mental imagery about death, impulsivity and exposure) 308 
distinguished suicide attempt from suicidal ideation, whereas motivational factors did not117. Such ways of 309 
understanding suicidal ideation and suicidal behaviour may be particularly informative in terms selecting 310 
psychotherapeutic approaches that will be most suited to the individual’s needs.  311 
[H3] Socioeconomic, environmental and other contextual factors associated with suicide risk. Important social and 312 
economic factors that are associated with suicide include relationship breakdown, low socioeconomic position, job loss, 313 
low income and debt. In addition, other social factors that are associated with suicide include poor social stability, 314 
stringent sociocultural norms, economic turmoil, socioeconomic position (having poor family connectedness, being 315 
single, having a low income and/or being in debt), being in a LGBT+ group or being bullied107,118-121. Some socioeconomic 316 
risk factors for suicide may operate differently in different social contexts; for example, the risk of suicide amongst 317 
individuals from minority ethnic groups is higher when individuals live in areas that have a low proportion of people 318 
from the same minority ethnic groups, compared with individuals living in areas that have a higher proportion of people 319 
from minority ethnic groups 122. In addition, some of these factors may act more immediately to precipitate suicidal 320 
behaviour, such as job loss and relationship breakdown107. Social isolation, for example resulting from anxiety, 321 
bereavement or social exclusion107,118, is also a strong contributor to suicide risk, whether isolation is measured 322 
objectively (such as living alone) or through perceived loneliness123. Conversely, clusters of suicide deaths may occur, 323 
particularly in young people, through social contagion, and these may account for up 1–2% of suicides in children and 324 
young people124.  325 
Among the environmental-based risk factors for suicide, one of the most important is access to means. To this end, 326 
there is a large volume of work showing the effect of access to more lethal means as an important predictor of 327 
suicide125. Of interest, these are modifiable risk factors and an important aspect of preventive efforts is based on 328 
decreasing access to lethal means (see Prevention strategies, below).  329 
[H2] Neurobiology of suicidal behaviour 330 
Suicidal behaviour is associated with widespread neurobiological changes throughout the brain that affect a number of 331 
different functional pathways. However, the extent to which these changes are specific for suicide and suicidal 332 
behaviour or are shared with depression and other psychopathologies is not always possible to determine given the 333 
intricate relationships between these phenotypes (Figure 5). 334 
[H3] Monoamine dysregulation in suicidal behaviour. The serotonin pathway is by far the best described pathway in 335 
depression and several alterations in this pathway have been associated with suicidal behaviour. Indeed, serotonergic 336 
neurons126, specifically, and altered serotonin function have been implicated in depression and suicide127-129. For 337 
example, studies using postmortem brain tissues of individuals who died by suicide have demonstrated decreased levels 338 
of 5-hydroxyindoleacetic acid (5-HIAA)127, which is a serotonin metabolite, and a compensatory increase in the raphe 339 
nuclei of serotonergic neurons130,131 and expression of tryptophan hydroxylase (TPH), a key enzyme in serotonin 340 
biogenesis132,133. In addition, dysregulated serotonin transmission has been demonstrated in both brain tissue134,135 and 341 
cerebrospinal fluid of individuals with suicidal behaviour136. An outstanding complication in the study of factors 342 
associated with suicidal behaviour is the high degree of comorbidity between depression and suicidal behaviour, yet 343 
some work has successfully shown discrete changes in expressions of both the serotonin transporter (SERT) and 344 
serotonin receptor 1A (5HT1A) in the midbrain in people with suicidal behaviour, compared to depressed individuals 345 
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without suicidal behaviour134,137. Further investigation of alternative serotonin receptors138, including those resulting 346 
from mRNA editing of serotonin receptor transcripts139-142, may lead to new avenues of investigation of the role of 347 
serotonin in suicidal behaviour.  348 
[H3] Stress response and the HPA axis. In normal situations, cortisol release is triggered by stress; its release is 349 
controlled by a feedback loop in which glucocorticoid receptors in the hypothalamus and other brain regions, including 350 
the hippocampus, are negatively regulated by cortisol binding and lead to the inhibition of cortisol release29. Altered 351 
cortisol reactivity may increase the risk of suicidal behaviour29,80, although studies have provided contradictory results 352 
regarding the direction of association, which seems to be moderated by several factors such as age143, family history of 353 
suicidal behaviour80,144 and history of ELA145, among other variables. Indeed, the epigenetic regulation of genes 354 
associated with ELA is exemplified by alterations to the HPA axis29,60,146. Individuals who experienced severe abuse during 355 
childhood, have increased methylation of a regulatory region of NR3C1 (encoding the glucocorticoid receptor) in the 356 
hippocampus58, compared with either people who were not abused or to psychiatrically healthy controls, and some 357 
evidence suggests that various forms of severe adversity affect the methylation status of NR3C1 exons in central and 358 
peripheral tissues29,145. In addition, specific sequence variants of FKBP5, which encodes a protein that downregulates 359 
glucocorticoid receptor signalling, are associated with increased depressive symptoms and suicidal behaviour in people 360 
with ELA147,148, presumably due to increased cortisol secretion and the development of anxiety traits. Other candidate 361 
targets of epigenetic regulation that might explain the link between ELA and altered cortisol control, include SKA2, which 362 
encodes the spindle and kinetochore associated protein 2149,150. 363 
In addition to alterations of the HPA axis, the polyamine stress response system seems to be differentially regulated in 364 
individuals with suicidal behaviour, although this pathway has been less thoroughly investigated than the HPA axis29. To 365 
this end, evidence that some polyamines exhibit anti-depressant-like effects151,152 suggests that alterations to the 366 
polyamine pathway may be an important contributor to suicidal behaviour.  367 
[H3] Neurotrophic pathways. Expression of neurotrophic genes, such as BDNF (encoding brain-derived neurotrophic 368 
factor, BDNF) and NTRK2 (encoding the BDNF receptor, tyrosine kinase B, TrKB), are decreased in the brains of 369 
individuals who died by suicide compared with controls153,154. The link between BDNF and suicide has been studied 370 
intensively, and several studies have demonstrated altered BDNF expression in suicide in the sera of people who 371 
attempted suicide and in the brains of people who died by suicide155,156, although to what extent these results are 372 
accounted for by underlying psychopathology is unclear. This altered expression is at least partially due to the epigenetic 373 
control of BDNF expression through methylation of its promoter; indeed, altered methylation of the promoter or exon 4 374 
has been demonstrated in the brains of people who died by suicide157 and in peripheral tissues of individuals who 375 
attempted suicide158. Additional evidence for the alteration of neurotrophic pathways in suicide is evidence of 376 
epigenetic regulation of TrkB-T1 (an astrocyte-specific variant of the BDNF receptor) in the brains of individuals who died 377 
by suicide, both through methylation of its promoter and through control by miRNA miR-185159,160. 378 
[H3] Glutamatergic and GABA-ergic dysfunction. Evidence from neuroanatomical studies of individuals with depression 379 
and suicidal behaviour have demonstrated changes in density of glutamatergic neurons and glial cells161,162, and the 380 
volume163 of the hippocampus, which relies on excitatory neurotransmission via glutamatergic signalling and is involved 381 
in learning and memory164. In brain tissue from individuals with depression (most of whom died by suicide), glutamate 382 
transporter expression is decreased165, whereas N-Methyl-D-aspartate (NMDA) receptor (a glutamate receptor) 383 
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expression is increased166 in the locus coeruleus, suggesting dysregulation of glutamatergic signalling. Importantly, some 384 
of the specific proteins the glutamate pathway that have been associated with suicidal behaviour (such as glutamate-385 
ammonia ligase, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA), NMDA and kainite glutamate 386 
receptors), have also been implicated in cognitive deficits167. GRIN2B, GRIK3 and GRM2 are among the glutamatergic 387 
genes that appear to be specifically upregulated in people who died by suicide, as opposed to MDD168, with a 388 
concomitant downregulation of the GLUL protein in astrocytes169. The glutamatergic pathway has become a particular 389 
point of interest in recent years owing to its probable involvement in mediating the potent antidepressant and anti-390 
suicidal activity of the NMDA receptor-antagonist ketamine170-172, which not only leads to sustained effects in animals173 391 
and humans172,174, but also appears to act through multiple mechanisms, including the inhibition of BDNF secretion by 392 
astrocytes175, upregulation of insulin-like growth factor 2 in the hippocampus176, and through regulation of AMPA and 393 
NMDA receptor expression levels177. In addition to the glutamate pathway, γ-aminobutyric acid (GABA)-associated 394 
genes, including the GABA-A and GABA-B receptors, are disrupted in the brains of individuals who died by suicide178, 395 
particularly in regions linked to executive function179,180 and the stress responses181, as well as in the integration of 396 
cognitive activity with affective experience. 397 
[H3] Immune function and inflammation. Inflammatory responses have drawn a great deal of attention in recent years, 398 
with several lines of evidence suggesting a link between inflammation and depression182,183. Indeed, in individuals with 399 
somatic disease, disorders with a strong inflammatory component, such as autoimmune disease184, and patients 400 
receiving cytokine therapy185, are more likely to develop depression than those who do not experience inflammation. 401 
The role of inflammation in suicidal behaviour has been explored through a number of studies that identified increased 402 
proinflammatory cytokines such as tumor necrosis factor, IL‑6 (Ref186), IL-8 (Ref187) and IL-1β188 in individuals who 403 
attempted suicide or who died by suicide. In particular, increased plasma IL-6 levels have been associated with 404 
impulsivity and violent suicide attempts189, thereby linking pro-inflammatory responses to the impulsive endophenotype 405 
for suicidal behaviour. High levels of inflammation may also be a tool to differentiate suicidal ideation from depression 406 
in adults190, and several authors have indicated that systemic inflammation in depression could be linked to a leaky gut 407 
(that is, abnormal permeability of the intestinal walls), which could expose bacterial molecular motifs to the immune 408 
system191. Other molecules that have been associated with suicidal behaviour include IL-2186 and vascular endothelial 409 
growth factor192, which are decreased in individuals with suicidal behaviour. Altered levels of quinolinic acid (an agonist 410 
of NMDA glutamate receptors) and kynurenic acid (an antagonist of NMDA, AMPA and kainate glutamate receptors), 411 
have also been reported in individuals with suicidal behaviour184,193. Of particular interest are the studies with 412 
Toxoplasma gondii, a brain-tropic nematode, which may increase the risk of self-directed violence, and risk of suicide 413 
attempt194,195. To this end, T. gondii infection is thought to trigger an immune response in the brain that could lead to 414 
decreased tryptophan availability, decreased serotonin biosynthesis, and increased levels of kynurenic acid196,197. Of 415 
note, T. gondii infection may also amplify specific behavioural traits that are linked with suicidal behaviour, such as 416 
aggression in women and impulsivity in men198,199. 417 
[H3] Brain-gut axis. A new avenue that has garnered much enthusiasm in psychiatry and beyond is the potential 418 
contribution of the gut microbiome to psychopathology200. Evidence that intestinal flora may influence mood states has 419 
been mounting201, with some studies demonstrating that certain bacterial strains can produce molecules to mimic 420 
dopamine signalling and to counter inflammation202. Although no findings have suggested a direct influence of the gut 421 
microbiome on suicidal behaviour, evidence of its effect on mood has been growing. As this nascent field begins to 422 
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produce more results, concrete treatment targets might emerge for depression, suicidal ideation, and suicidal 423 
behaviour. 424 
 425 
[H1] Diagnosis, screening and prevention  426 
Suicide prevention draws on a wealth of complementary approaches that span individual and populational approaches, 427 
and include diverse strategies for the assessment of suicide risk and prevention of suicide and suicidal behaviour (Figure 428 
6). 429 
[H2] Assessment and determination of risk 430 
As previously mentioned, no single risk factor, whether previous suicidal ideation or behaviour, mental health disorder, 431 
or other psychological traits, is a strong predictor of suicidal behaviour203,204. Consequently, there is a nearly universal 432 
acknowledgement that prediction of suicide and suicidal behaviour can only improve substantially over chance by the 433 
examination of multiple risk factors simultaneously, with a specific focus on imminent suicide risk203,205. To this end, it is 434 
important to note that the factors that contribute to risk of suicidal ideation are different than those that contribute to 435 
the transition from suicidal ideation to suicidal behaviour. Broadly speaking, among psychiatric disorders that can 436 
contribute to suicidal behaviour, mood disorders are most closely associated with suicidal ideation, whereas disorders of 437 
distress (such as panic disorder or post-traumatic stress disorder) or of disrupted impulse control (such as substance 438 
abuse or behavioural disorders) can contribute to the transition from suicidal ideation to suicidal behaviour88. In 439 
addition, two important transdiagnostic risk factors for suicide and suicidal behaviour are sleep problems (including 440 
reduced sleep, insomnia and nightmares) and chronic pain.  441 
Several approaches have attempted to examine individual at high risk of suicide by assessing multiple risk factors 442 
simultaneously, such as have included the use of standard suicide risk scales, computerized adaptive tests (CATs) and 443 
machine learning of electronic health records. For example, one systematic review of screening instruments for 444 
predicting future episodes of deliberate self-harm (including suicide attempts), primarily in psychiatric populations, 445 
demonstrated that the SAD PERSONS scale had low sensitivity but high specificity, with the opposite for the MSHR206. In 446 
addition, the MSHR had a fair accuracy at predicting deliberate self-harm in individuals who had engaged in previous 447 
self-harming behaviour (with an Area Under the Curve (AUC) of 0.72) in one prospective study, but none of the 6 rating 448 
scales examined performed better than a global clinical rating of risk (AUC 0.74)207. Other studies, including a systematic 449 
review, confirmed that there is no evidence to support the use of risk assessment instruments as predictors of suicidal 450 
behaviour among patients with a psychiatric disorder208,209. 451 
The last clinical contact for the majority of people who die by suicide is either in an emergency department or in primary 452 
care.210 Screening for suicide risk in emergency departments (EDs) is justified because as many as 1 in 5 individuals who 453 
die by suicide have visited the ED within 4 weeks of their death210 and, conversely, a visit to the ED for a mental health 454 
reason is a predictor of suicidal behaviour 87. In addition, other reasons for visiting the ED can increase the risk for 455 
suicide (such as trauma or alcohol intoxication), and nearly half of individuals who screen positive for suicide risk in the 456 
ED do not spontaneously communicate suicidal ideation211,212.  457 
Although suicide risk screening, which aims to detect any signs of suicidal ideation or behaviour, in EDs is not routine, it 458 
is a recommended aspirational goal that is variably, but increasingly being implemented in EDs in the United States 459 
(https://www.jointcommission.org/assets/1/6/NPSG_Chapter_HAP_Jan2019.pdf). The 4-item ASQ213 for children and 460 
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adolescents shows high sensitivity (93%) but lower specificity (43%) for predicting future suicide-related visits to the ED 461 
in the subsequent 6 months. The EDSAFE/SAMSHA decision support tool was prospectively evaluated in adult attendees 462 
in an ED. Two items, having thought of a suicidal plan and having a history of a past attempt, both showed very high 463 
sensitivity (86.2–94.5%) for predicting a suicide attempt within the subsequent 6 weeks, but with low sensitivity (15.0–464 
29.7%). Taken together, these two items predicted 83% of all suicide attempts within 6 weeks214. However, screening in 465 
EDs without an associated follow-up intervention to bolster treatment adherence and adherence to a safety plan is no 466 
better than usual care, whereas screening coupled with follow-up calls can reduce suicide attempts relative to usual care 467 
in the ED215. In addition, screening in primary care settings is also important, as the last clinical contact of people who 468 
died by suicide is most often in primary care210. In addition, one study demonstrated that those who reported frequent 469 
or daily suicidal thoughts in Item-9 of the PHQ-9 (a screening tool for depression that is typically delivered in primary 470 
care settings) were at markedly increased risk for suicide and suicide attempts216. However, this item has relatively low 471 
sensitivity, and, indeed, 39% of those who made suicide attempts, and 36% of those who died by suicide within 30 days 472 
of completing a PHQ-9 reported no suicidal ideation at the time216. 473 
[H3] Computerized adaptive tests. One challenge to screening for suicidal risk is that it is multi-dimensional and not 474 
easily or accurately captured in a scale that focuses on a single disorder such as depression. Moreover, as described 475 
above, current approaches to screening for suicide risk have a high sensitivity but a lower specificity, which is 476 
problematic, for example, in ED settings. 213 To address this problem, CATs have been developed for suicidal risk that 477 
personalize the presentation of items or questions to an individual based on their responses to previous items or 478 
questions217. This technique allows for the assessment of a wide range of potentially relevant risk factors in a brief 479 
questionnaire of 6-10 items. A CAT for the detection of suicidal ideation and behaviour has been developed using a 480 
sample of adult outpatients with a pre-existing mental health condition, and has demonstrated strong discriminative 481 
validity, with both high sensitivity and sensitivity in the identification of individuals at moderate and high risk for suicidal 482 
behaviour in the ED218. Similarly, a CAT for assessing suicidal ideation or behavior has been developed for children and 483 
adolescents that shows high convergent and discriminative validity. However, predictive validity of both the adult and 484 
paediatric CATs for assessment of suicidal risk have yet to be reported218,219. 485 
[H3] Electronic health records. Machine learning is now being used to try and identify precursors of suicidal behaviour 486 
and suicide that can be detected from patients’ medical records. The advantages of this approach are that it provides a 487 
sample size large enough to detect effects on suicide and suicide attempts, it bypasses patient self-report, and it allows 488 
the testing of the effect of a combination of risk factors, each of which might only make a small individual contribution 489 
to suicidal risk. In addition to a review of diagnoses, medication and service use, some studies have included natural 490 
language processing of the clinician’s notes to try and identify phrases associated with risk or protective factors for 491 
suicide (such as social support or clinician optimism)220,221. Collectively, these approaches could alert clinicians that their 492 
patients are at increased risk of suicide, thereby facilitating referral to appropriate services.  493 
One study of machine learning of health records for the prediction of suicide and suicide attempts examined the medical 494 
and psychiatric records of ~3 million patients with at least one mental health diagnosis across seven different health 495 
care systems222. In this study, an algorithm was developed that could identify 5% of the population that accounted for 496 
43-48% of the suicides and suicide attempts, and was able to predict suicide and suicide attempts in the next 90 days 497 
with a specificity of ~70% and a sensitivity of ~80% in both specialty mental health and primary care settings222. The list 498 
of predictor variables was primarily those that have a well-established association with suicide risk (such as depression, 499 
 
 
14 
 
 
alcohol abuse, drug abuse or a history of a suicide attempt), but the power of this approach was in the ability to test the 500 
predictive power of the combination of many variables simultaneously. Although these results are promising, it will be 501 
important to prospectively test if algorithms generated from the use of artificial intelligence improve clinical knowledge 502 
for assessing suicide risk and to carry out randomized controlled trials (RCTs) to assess the effect of algorithm use on 503 
clinical outcomes223.  504 
[H2] Prevention strategies  505 
One framework for suicide prevention that was proposed in the mid-1990s224,225 and that is still widely used today was 506 
built on other frameworks for the prevention of mental disorders226 and physical disorders227. The framework takes a 507 
risk factor-based approach to suicide prevention, classifying suicide prevention activities as universal, selective or 508 
indicated on the basis of their target groups (Figure 6). Each type of intervention is discussed below, along with 509 
examples. The examples are by no means exhaustive but are intended to give an overview of the types of preventive 510 
interventions that have been trialled. 511 
[H3] Universal interventions. Universal interventions aim to favourably shift risk and protective factors across the entire 512 
population, rather than in specific groups of individuals. In general, universal interventions usually either affect the 513 
social environment or promote resiliency within individuals226, and target risk factors, without necessarily identifying 514 
individuals who have those risk factors. For example, a number of universal interventions have targeted ‘access to 515 
means’ as a risk factor for suicide, without specifically identifying those whose access might place them at risk. Examples 516 
of these efforts include banning pesticides228, withdrawing medications associated with suicide (such as co-proxamol) 517 
from the market229 , removing charcoal from retail outlets230, equipping vehicles with catalytic converters231 and 518 
installing barriers on bridges and cliffs232,233. Other examples of universal interventions acknowledge the influential role 519 
of the media; to this end, many countries and organizations have produced guidelines for journalists to encourage the 520 
responsible reporting of suicide in the media, in recognition of the fact that media presentations of suicide, for example, 521 
those glamorizing the decedent, can lead to ‘copycat’ acts234. More recently, efforts have shifted to adapting these 522 
guidelines for use in social media235, with, for example, resources being developed to assist young people to have safe 523 
discussions about suicide online236, and reducing the availability of online information concerning lethal means237. In 524 
addition, suicide prevention media campaigns have also gained traction, as the potential of the media as a force for 525 
good in suicide prevention has been recognized. These campaigns are delivered to the population as a whole, usually 526 
across multiple media platforms, and most have brief community service announcements at their core and contain 527 
messages about offering or seeking help238,239. Other examples of universal interventions are delivered in specific 528 
settings and are usually designed to raise awareness about suicide and its prevention; often these interventions target 529 
young people and take place in schools, universities and workplaces240. 530 
[H3] Selective interventions. Selective interventions target subgroups who exhibit risk factors that predispose them to 531 
suicidal thoughts or behaviours, but who do not currently exhibit those behaviours226. Many selective interventions 532 
directly or indirectly target people with psychiatric disorders; for example, specific pharmacological treatments for mood 533 
disorders have been trialled (see below, Pharmacological interventions for suicidal behaviour). Similarly, interventions 534 
that aim to better equip general practitioners to detect, diagnose and manage depression (typically involving the 535 
provision of education and guidelines) have also been introduced, with the rationale that many people with depression 536 
will not see a specialist mental health care provider, but will receive care from a general practitioner241.Other selective 537 
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interventions target people with socioeconomic, environmental or contextual risk factors for suicide (see 538 
Mechanisms/pathophysiology, above), such as those experiencing bullying or social isolation. Selective interventions 539 
designed to reduce bullying and social isolation are often school-based and are tailored towards particular subgroups, 540 
such as LGBT+ young people. For example, some schools have Gay-Straight Alliances (GSAs) that provide a safe and 541 
supportive environment to LGBT+ students, and there is emerging evidence that these may have positive effects in 542 
reducing suicidal ideation and suicide242. 543 
[H3] Indicated interventions. Indicated interventions are designed for people who are already starting to exhibit suicidal 544 
thoughts or behaviours, identified through screening programmes or by clinical presentation. As these interventions 545 
target people who already have suicidal ideation or suicidal behaviours, some individuals have argued that, unlike 546 
universal and selective intervention strategies that constitute true prevention, indicated intervention strategies fall into 547 
the realms of early intervention224. A key example of indicated intervention is the provision of psychosocial interventions 548 
to those who present to an ED or other healthcare setting following an episode of self-harm243 . Such interventions 549 
include psychological therapies (see, Psychological interventions for suicidal behaviour, below) and social approaches 550 
that are designed to provide ongoing support (such as case management244 and regular communication through 551 
channels like postcards or text messages245). Telephone crisis services (sometimes called ‘hotlines’) constitute a further 552 
example of an indicated intervention246. These services have existed since the 1950s247, and many have now embraced 553 
newer technology like online chat and text-messaging services248. 554 
[H3] Multi-component interventions. Universal, selective and indicated interventions are often delivered in 555 
combination through what is often termed a ‘systems-based’ approach249. This approach is sometimes delivered in local 556 
regions or communities, such as with the Alliance Against Depression model. This model was initially implemented in 557 
Nuremberg (Germany), and included a suicide prevention media campaign (universal intervention), education for 558 
general practitioners and gatekeeper training for frontline workers and other professionals (selective interventions) and 559 
an ‘emergency card’ which gives people who have made a suicide attempt ready access to professional help, as well as 560 
additional ‘self-help’ activities (indicated intervention). Following its demonstrated 24% reduction in suicidal 561 
behaviour250, the Alliance Against Depression model has since been adopted in a number of other regions in Europe, 562 
with the inclusion of an additional universal intervention (restricting access to means)250. Beyond regions and 563 
communities, multi-component interventions have also been delivered in specific settings (such as health services251 and 564 
schools252) and to particular population groups (for example, armed forces personnel253). 565 
[H3] Evaluation of suicide prevention interventions. One systematic review has synthesised the evidence around 566 
specific suicide prevention interventions254, and identified only a few interventions with unequivocal evidence of 567 
effectiveness in reducing suicide-related outcomes (suicides, suicide attempts and suicidal ideation) or which showed 568 
substantial promise. This review concluded that restricting access to means can prevent suicide and that school-based 569 
awareness programmes can reduce suicide attempts. Certain psychological treatments, particularly cognitive 570 
behavioural therapy (CBT), are also important in the suite of strategies to prevent suicide. Other interventions, such as 571 
pharmacological treatments (for example, lithium or antidepressants) also demonstrated benefits, although their effects 572 
might be specific for particular population groups.  573 
Although this review highlights the effectiveness of several interventions, it is striking that there are many interventions 574 
for which the evidence base is rudimentary. There are a number of reasons for this poor evidence base, not the least of 575 
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which is that RCTs are often difficult to mount in the area of suicide prevention. This difficulty is partly because of the 576 
low base rate of suicide (which has implications for the sample size needed to demonstrate the effect of an intervention) 577 
and partly because it is unethical to withhold a potentially life-saving intervention from the control group. These 578 
problems are compounded in the case of universal interventions, which typically target whole communities. 579 
Increasingly, suicide prevention researchers are looking to alternative or augmented evaluation designs to strengthen 580 
the evidence base255. In the field, there is a recognition that RCTs are not always possible, and that well-designed 581 
ecological studies (observational studies in which groups or populations, rather than individuals, are studied to provide 582 
evidence of change associated with a particular intervention) will sometimes provide the best available evidence255. 583 
Indeed, the systematic review included ecological designs, and the authors of this review observed that these designs 584 
were particularly common in assessing the effect of population-level restriction of access to means254. In addition, 585 
suicide prevention researchers are borrowing methodological approaches from disciplines like programme evaluation to 586 
evaluate complex interventions (such as designing programme logic models and triangulating data from a range of 587 
sources)255. They are also using increasingly sophisticated analysis strategies to analyse evaluation data (for example, 588 
interrupted time series analyses across multiple sites)255. In addition, some researchers are also beginning to go beyond 589 
effectiveness to consider the cost-effectiveness of interventions256. 590 
 591 
[H1] Management 592 
In the past two decades, most efforts to develop suicide-specific psychosocial interventions have moved away from the 593 
view that treating the underlying psychiatric disorder would resolve suicidal urges and thoughts, to a perspective that 594 
suicide-specific treatments are necessary in addition to interventions for primary psychiatric disorders. Furthermore, in 595 
recognition that many people who become suicidal have limited access to behavioural treatments or do not wish to 596 
receive these treatments, brief suicide prevention approaches with limited or no health professional intervention have 597 
been developed (Box 2).  598 
[H2] Longer-term psychosocial interventions. Overall, psychosocial interventions, irrespective of type, have been shown 599 
to reduce suicide attempts. One meta-analysis demonstrated that in adult and adolescent patients (hospitalized or not, 600 
and presenting with a variety of features, such as borderline personality disorder, depression, schizophrenia-spectrum 601 
disorders), and in patients with or without history of suicidal ideation or behaviour, psychosocial interventions were 602 
associated with significantly fewer suicide attempts during follow-up compared with those who received treatment as 603 
usual257. In addition, sensitivity analyses showed that psychosocial interventions are effective in outpatient settings 604 
among those with borderline personality disorder, irrespective of suicidal history257. The beneficial effect of psychosocial 605 
interventions demonstrated in this meta-analysis is consistent with a large-scale, register-based propensity score 606 
matching study which found that those who received a psychosocial intervention after self-harm were less likely to die 607 
by suicide at long-term follow-up258. 608 
Of all the longer-term psychosocial interventions, cognitive therapy (CT) and cognitive behaviour therapy (CBT) have 609 
received the most research focus243,257,259. CT and CBT are types of psychological therapies that encourage an individual 610 
to manage their problems by changing the way in which they think and behave. Recent reviews confirm that CT and CBT 611 
that targets suicidal thoughts and behaviours in high-risk adults can reduce the incidence of self-harm at 6 months (OR 612 
0.54, 95% CI 0.34–0.85) and 12 months (OR 0.80, 95% CI 0.65–0.98 )243. In addition, in one RCT of active duty soldiers, 613 
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brief CBT (12.5 hours per patient) reduced the odds of suicide attempts in the 24-month follow-up compared with 614 
treatment as usual (HR 0.38, 95% CI 0.16–0.87, NTT 3.88)260. However, it is important to note that there is considerable 615 
study heterogeneity in the CT and CBT field243,259 and one analysis of studies demonstrated that the favorable effect for 616 
CBT was strongest when treatment as usual was not clearly described261.  617 
Dialectical behaviour therapy (DBT) is a cognitive behavioural treatment (including individual psychotherapy and weekly 618 
skills groups) that combines the change-focused aspects of CT with acceptance-based work262. Many studies of DBT have 619 
focused on patients with borderline personality disorder243,263,264. Although individual studies have provided evidence 620 
that DBT reduces suicidal ideation and suicide attempts, one systematic review examining treatment of patients 621 
(regardless of diagnosis) who have self-harmed within 6 months prior to treatment initiation concluded that although 622 
DBT was associated with decreased frequency of self-harm, it did not reduce the number of patients who repeated self-623 
harm during follow-up243.  624 
Other approaches include the collaborative assessment and management of suicidality (CAMS)265, a therapeutic 625 
framework to guide and manage suicide risk and inform treatment planning, mindfulness-based interventions, and 626 
acceptance and commitment therapy, a cognitive behavioural treatment that aims to promote psychological flexibility 627 
using 6 core processes including acceptance and commitment to action266. Although CAMS has been shown to reduce 628 
suicidal ideation at 3 months267, whether this treatment is effective for reducing suicide attempts has not yet been 629 
established267,268. Although interest in mindfulness-based interventions has grown in recent years, it is not yet clear 630 
whether these interventions reduce suicidal ideation or suicidal behaviour269. There is also some preliminary evidence 631 
for acceptance and commitment therapy in reducing suicidal ideation, although further studies are required270.  632 
Evidence on the use of psychosocial treatments in children and adolescents, irrespective of type, remains weak257,271,272. 633 
An evidence update concluded that DBT was the only intervention to meet the threshold for ‘well established 634 
treatments’ for reducing suicidal ideation and suicidal behaviour in children and adolescents273. Where there was 635 
probable or possible evidence for efficacy, these interventions tended to come from single studies272,273. However, an 636 
updated systematic review found that, if DBT is treated as a type of CBT, then there is evidence for the positive effects of 637 
CBT on self-harm in adolescents274. The authors of this study also noted that CBT with a family systems component are 638 
promising274. In addition, mentalization may also be effective in adolescents who self-harm275.  639 
Very few studies have focused on preventing suicidal ideation or behaviour in older adults276. However, one study 640 
demonstrated that problem-solving therapy was associated with a reduction in suicidal ideation at 12 and 36 weeks, 641 
compared with supportive therapy277. In addition, findings from a pilot study of a 16-session course of interpersonal 642 
psychotherapy adapted for older adults found reduced suicidal ideation post-treatment278.  643 
No evidence from RCTs supports any of these psychosocial interventions reduce the risk of suicide279. However, it is 644 
important to note that absence of evidence does not mean that these interventions are not effective; but rather, for the 645 
most part, that studies have been insufficiently powered to detect a reduction in suicide, given the relatively low 646 
frequency of deaths by suicide. Three other challenges to the management of suicide risk are important to highlight, 647 
namely that men are less likely to seek help than women280, that men who die by suicide are less likely to be in contact 648 
with clinical services than women prior to death281, and that it is not clear whether psychosocial interventions are as 649 
effective for men than for women243. 650 
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[H2] Brief psychosocial interventions. Brief interventions to prevent suicidal behaviour are of great interest because 651 
they are easy to implement, inexpensive and require limited staff resources. These interventions are typically delivered 652 
in one session or via several brief contacts in person, by phone or mail. Typically, these interventions are often 653 
implemented with patients who had attended the ED for a suicidal crisis, most often a suicide attempt. Overall, the 654 
interventions target behaviour rather than symptoms associated with suicidal crises. The interventions, to varying 655 
degrees, focus on informing people about suicidal behaviour, helping people to become aware of problems, 656 
vulnerabilities and events linked to the behaviour, motivating people to engage in safety planning and help-seeking, 657 
problem solving and developing practical strategies to manage future suicidal crises along with connecting to social and 658 
professional support. 659 
 660 
[H3] Caring Contacts. This approach, which was first tested more than four decades ago282, refers to the routine sending 661 
of brief non-demanding messages (via, for example, postal mail, postcards, email, texting and telephone) that express 662 
caring concern to suicidal patients following discharge from inpatient treatment. This intervention was shown to 663 
decrease suicide risk in one meta-analysis (OR 0.20, 95% CI 0.09–0.42)279, although this finding needs replication. A 664 
recent caring contacts (delivered via text message) trial for military personnel yielded inconsistent findings on the 665 
effectiveness of messages between primary (current suicidal ideation and hospitalization or medical evacuation due to 666 
suicide risk) and secondary outcomes (worst-point suicidal ideation, emergency department visits, and suicide 667 
attempts)283. 668 
[H3] No-suicide contracts. Another form of brief intervention usually takes the form of asking patients to promise not to 669 
engage in suicidal behaviour and to contact professionals during times of crisis. These interventions have been used in 670 
various contexts, including emergency helplines and inpatient units. The contracts usually include a statement of assent, 671 
details of the duration of the agreement and a contingency plan if the person feels unable to uphold the agreement. 672 
However, there is a lack of data supporting their effectiveness284 and they have fallen out of favour. 673 
[H3] Safety Planning Intervention or Crisis Response Planning. The Safety Planning Intervention (SPI285) is a brief 674 
intervention that involves patients engaging in a suicide narrative that is aimed at identifying warning signs, and 675 
provides individuals with a prioritized and specific set of coping strategies and sources of support that they can use if 676 
suicidal thoughts re-emerge. The intent of the SPI is to help individuals lower their imminent risk for suicidal behaviour 677 
by consulting a predetermined set of potential coping strategies and social supports. SPI has 6 steps: Identify the 678 
warning signs; apply internal coping strategies; use people or social settings that could serve as a distraction; reach out 679 
to friends and family members who can provide support; contact professionals and agencies; limit access to lethal 680 
means. 681 
 SPI, in combination with follow-up calls (known as SPI+), is effective in reducing incidence of suicidal behaviour and 682 
increasing treatment engagement in the 6 months after discharge from the ED286. Crisis response planning is an 683 
abbreviated form of safety planning that uses 4 of 6 elements of the SPI (without social interaction as a means of 684 
distracting from suicidal thoughts and counselling to limit access to lethal means). Compared with a contract for safety, 685 
crisis response planning is more effective in preventing suicide attempts, resolving suicidal ideation and reducing 686 
inpatient hospitalization among high-risk active duty military personnel287. In addition, the ED-SAFE intervention includes 687 
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a safety planning aspect (self-administered), along with a secondary suicide risk screening designed for ED physicians to 688 
evaluate suicide risk following an initial positive screen, and a series of telephone calls with the optional involvement of 689 
a friend or relative of the individual for 52 weeks following an ED visit. The ED-SAFE intervention resulted in fewer 690 
suicide attempts over a year compared to treatment as usual215. 691 
[H3] Additional brief interventions. Several other types of brief interventions have been described. The Attempted 692 
Suicide Short Intervention Program (ASSIP)288 is a multi-session brief intervention that utilizes several elements of SPI 693 
and the crisis response plan in that it combines psychoeducation, a recorded patient-centered narrative description of a 694 
recent suicide crisis, safety planning and review of the recording to help continued long-term outreach contact. The 695 
ASSIP differs from other brief interventions in that it utilizes review of the recorded suicide narrative with the patient. 696 
ASSIP is administered in three weekly face-to-face therapy sessions that are supplemented by regular, personalized 697 
letters to the participants for 24 months.  One recent study has demonstrated an 80% reduced risk of participants 698 
making at least one repeat suicide attempt when ASSIP was administered in addition to usual clinical treatment, 699 
compared with usual treatment with a single assessment interview288. In addition, ASSIP led to fewer suicide attempts 700 
but had no effect on suicidal ideation288. 701 
Another type of brief intervention — the Volitional Helpsheet — consists of a table with two columns and is designed to 702 
enhance self-determination with respect to self-harm. One column lists theoretically derived critical situations (in which 703 
the individual might engage in self-harm) and the other lists alternative responses to self-harm. Although this 704 
intervention had no overall effect on the recurrence of self-harm, it has been shown to be effective in reducing the 705 
number of self-harm repetitions following a suicide attempt in those previously hospitalised for self-harm, compared to 706 
a control group receiving treatment as usual289.  707 
Similarly, in teens, two brief interventions — Teens Options for Change (TOC)290 and As Safe As Possible (ASAP)291 — 708 
yielded encouraging, yet non-significant results. These studies offered different interventions to increase emotional 709 
regulation and coping skills in patients at risk of suicide from ED and inpatient settings, respectively.  710 
[H2] Pharmacological interventions for suicidal behaviour 711 
[H3] Lithium. Among potentially anti-suicidal pharmacological agents (Box 2), lithium has been used the longest. The 712 
anti-suicidal effects of lithium have been reported for decades. However, most of the data supporting its utility in 713 
preventing suicide related outcomes derives from observational studies of patients followed clinically with lithium292,293 714 
and some studies have reported conflicting data294. More recently, several methodologically rigorous 715 
pharmacoepidemiological studies have been conducted, with >10,000 patients in each study295,296 and have strongly 716 
suggested that patients treated with lithium are relatively protected from suicide attempts, death by suicide, 717 
hospitalization for suicide attempts and other suicide related outcomes, compared with patients treated with valproate 718 
or other mood stabilizers. However, several RCTs that compared lithium to either placebo or to other mood stabilizers 719 
have been unable to demonstrate this effect297,298, although some had very modest sample sizes299. Of interest, two of 720 
these studies identified anti-suicidal effects based on secondary, post-hoc analyses297,300. Although some meta-analyses 721 
that compared lithium to antiepileptic drugs and placebo found little effect279,301, another recent meta-analysis with 722 
>6,500 participants demonstrated that, despite little effect on suicidal behaviour, lithium treatment was effective at 723 
reducing suicide deaths compared to placebo in people with MDD301. Importantly, the risk of suicidal behaviour was 724 
much greater before starting treatment with antiepileptic drugs compared with after treatment initiation in one 725 
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study302, whereas another study demonstrated no difference303; these findings are important, given the warning about 726 
possible increases in suicidal ideation in patients exposed to antiepileptic drugs by the US FDA.  727 
Proper interpretation of these contradictory results about the anti-suicidal properties of lithium is essential, given the 728 
toxicity of lithium in overdose and its relatively narrow therapeutic window. Observational studies, no matter how well 729 
controlled, may spuriously demonstrate the protective effects of lithium. For example, these studies cannot control for 730 
important variables that effect a clinician’s medication choice. Lithium toxicity and overdose risk may influence the 731 
likelihood of its prescription, particularly among individuals who are a greater risk of suicidal behaviour. Additionally, 732 
increased monitoring of patients who receive lithium may improve treatment efficiency and decrease suicide risk 733 
through repeated contact with clinical services. 734 
[H3] Clozapine. Clozapine was the first medication approved by the US FDA to prevent suicidal behaviour. It is indicated 735 
in schizophrenia, in which the lifetime rate of suicide deaths of patients is ~10% with ~50% of individuals attempting 736 
suicide304. Evidence supporting the use of clozapine for suicide came from the InterSePT study, a multicentre RCT that 737 
demonstrated the superiority of clozapine in decreasing the risk of suicide attempts and the other primary outcome 738 
variables in people with schizophrenia or schizoaffective disorder, compared with olanzapine304. Of note, this study 739 
reported no difference in the rates of suicide in the two treatment arms, although the total number of deaths was 740 
relatively small (5 with clozapine and 3 with olanzapine). More recently, a meta-analysis of observational and trial data 741 
demonstrated that clozapine, when taken consistently, decreased not only suicides, but other causes of mortality as 742 
well305, although this effect may be partially explained by closer monitoring of patients receiving clozapine treatment. 743 
Nonetheless, clozapine remains relatively underutilized for the prevention of suicidal behaviour in patients with 744 
psychosis, probably because of the required laboratory monitoring given the risk of neutropenia and agranulocytosis in 745 
patients treated with this drug306. 746 
[H3] Ketamine. The past decade has seen intense interest in the utility of ketamine as a potential anti-suicidal 747 
medication307 and its relatively novel mechanism of action has spurred a search for other drugs with similar mechanisms 748 
that might also be of use308. Several studies have examined the effect of ketamine on suicidal ideation, mostly in people 749 
with mood disorders309-311 and have demonstrated that ketamine decreases suicidal ideation independent of 750 
improvement in other mood symptoms,174,309-311 although one small study did not find this to be the case312. Of interest, 751 
the effects of ketamine on suicidal ideation may be linked to improvements in insomnia313, a clinical variable that has 752 
been linked to suicidal behaviour314. Several additional studies are underway to examine the effects of intranasal 753 
ketamine (esketamine, the S-enantiomer of ketamine) on suicidal ideation in various populations, with some 754 
encouraging results315. Clearly, intranasal administration route would facilitate the use of ketamine, were its therapeutic 755 
effects verified. Some of the questions remaining include the duration of its effects and whether repeated 756 
administration would be a practical and efficient approach. 757 
[H3] SSRIs. Selective serotonin reuptake inhibitors (SSRIs) are thought to have a more-pronounced effect on suicidal 758 
ideation than other antidepressants, based on >50 years of studies showing the importance of serotonergic dysfunction 759 
in suicidal behaviour61,129. Earlier studies were mostly secondary analyses of depression trials. In fact, of 10 such studies 760 
that compared the effects of serotonergic antidepressants to noradrenergic antidepressants on suicidal ideation, five 761 
studies favored serotonergic drugs316-320, one study favored a noradrenergic drug321, and four studies found no 762 
difference322-325. However, these studies used one item from a depression scale to measure suicidal ideation and did not 763 
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specifically recruit individuals with suicidal behaviour. However, one small pilot study using a double-blind, randomized, 764 
controlled methodology demonstrated that paroxetine was more effective in reducing suicidal ideation, even after 765 
adjusting for depression symptoms, compared with bupropion in patients with depression who had a past suicide 766 
attempts or active suicidal ideation326. Of note, benefit increased as baseline severity of suicidal ideation was higher. 767 
Clearly, more evidence is required to determine whether SSRIs are superior than other therapies for the treatment of 768 
people with depression who are suicidal, and trials would do well to specifically recruit those at risk for suicidal 769 
behaviour. There also appears to be an age-related effect of SSRIs on suicidal events. Indeed, in one meta-analysis of 770 
clinical trials, SSRIs appeared to increase the risk of suicidal events in those < 24 years of age, and protected against 771 
suicidal events in those >65 years of age327.  772 
[H3] Buprenorphine. The effects of buprenorphine have recently been studied for the treatment of suicidal ideation. A 773 
small RCT delivered promising results suggesting that patients with depression who received low-dose buprenorphine 774 
were more likely to show decreases in suicidal ideation after 2 weeks and 4 weeks of treatment328. Buprenorphine was 775 
well tolerated. Similarly, a 3-day study of men with depression and opioid use disorder also demonstrated decreases in 776 
suicidal ideation after a large dose of sub-lingual buprenorphine, although this trial was not placebo controlled329. Larger 777 
studies are needed to replicate the finding that opioids may improve suicidal ideation, and this is an observation that 778 
comports with the hypothesis that psychic pain is an important determinant of suicide risk330. 779 
[H1] Quality of life 780 
Quality of life is a multidimensional concept that includes physical, mental and social aspects of subjective satisfaction 781 
with one’s own life. Studies investigating health-related quality of life typically focus on the physical components and 782 
mental components in the context of either past suicidal ideation or past suicide attempt. For mental health outcomes, 783 
suicidal ideation and suicide attempt associate with trajectories of decreasing mental health over time.331 In addition, 784 
several factors are associated with reduced mental health components of quality of life assessments, such as being 785 
female, having borderline personality disorder or having high impulsivity, hopelessness or hostility332. Similarly, suicidal 786 
behaviour is associated with reduced physical health over time331,333, and depending on the method and severity of the 787 
suicide attempt, individuals might have with physical disabilities that directly affect their quality of life334. Moreover, 788 
reduced quality of life can also affect those who are close to the individual attempting suicide. Indeed, scores for 789 
depression and anxiety are higher, whereas scores for mental components of quality of life are lower in people who are 790 
related to an individual who died by suicide335.  791 
A continuing obstacle to suicide prevention and contributor to decreased quality of life in people who survive suicide 792 
attempts is the pervasive taboo surrounding suicidal ideation and suicidal behaviour. Although most countries have 793 
public health initiatives that are directed at breaking the stigma surrounding mental health issues, the perceived stigma 794 
associated with suicide is still an obstacle to help-seeking1,336 and, therefore, constitutes an important target for public 795 
health initiatives aiming to decrease suicide rates. Additionally, the stigma, or perceived stigma associated with suicide 796 
and suicide attempts is associated with reduced disclosure of personal or familial histories of suicidal behaviour and are 797 
associated with decreased self-esteem336. 798 
As noted above, the prevalence of suicidal ideation and suicide attempt are many times that of suicide, therefore the 799 
potential effect of suicidal ideation and suicidal behaviour goes beyond the direct loss of the individual. Studies 800 
investigating the economic burden of suicide and suicide attempt placed the cost of suicide at $58.4 billion in the USA in 801 
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2013, when considering only reported suicides and suicide attempts, and up to $93.5 billion when numbers are adjusted 802 
for under-reporting337. Of note, the costs were mainly due to lost productivity337. In addition, suicidal ideation and 803 
suicide attempt are associated with increased health care costs, with up to one-third of patient admissions in psychiatric 804 
hospitals attributed to suicidal ideation or suicide attempt332. These costs may be related to the direct treatment of 805 
injuries or to the psychological and social aspects of suicidal behaviour and their effect on others1. With an estimated 806 
per capita cost of suicide nearing $300 in the USA337, investments in suicide prevention efforts are paramount. 807 
 808 
[H1] Outlook 809 
Suicide and suicidal behaviour continue to present a challenge both clinically and socially, and our theoretical 810 
understanding of the process involved in development of suicide risk continues to evolve as we obtain more evidence on 811 
the epidemiological, biological, clinical and psychological fronts.  812 
Several factors regarding the detection and treatment of suicide continue to be explored, such as developing and 813 
validating clear assessment algorithms to assist clinicians in determining which of their patients are at greatest risk of 814 
suicide attempt or suicide and assessing the practicality of their implementation in clinical practices. In addition, 815 
understanding which psychological or pharmacological treatments are the most effective, and for whom, requires 816 
further study. On this point, >100 registered clinical trials for suicide are currently underway (Supplementary Table 1). 817 
These trials are investigating various interventions, including those based on psychological and behavioural approaches, 818 
pharmacological approaches, mixed approaches, use of medical devices, use of new media, screening, primary 819 
prevention, and reducing access to lethal means.  820 
Similarly, what biological mechanisms underlie the cognitive and behavioural changes associated with suicide risk, and 821 
how public policies can be tailored to better prevent, detect and treat at-risk groups to continue to decrease suicide 822 
rates across the globe, are important questions to address. In addition, efforts should also go into better understanding 823 
sex differences as they apply to pathology and interventions for suicidal behaviour. Given the important contribution to 824 
global suicide rates of easy access to pesticides and firearms, and the clear evidence that selective measures to reduce 825 
access to these means may have on suicide rates, single measures such as legislation for stricter regulation of firearm 826 
access in the USA or further regulation on access to pesticides in China and other countries in Asia may have a 827 
tremendous effect on global suicide rates125. With suicide rates continuing to rise at an alarming rate in some countries1, 828 
it is evident that suicide will remain an important public health concern, and one that can only be addressed through 829 
concerted, multidisciplinary and multifaceted efforts.  830 
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Figure 1. Global variations in suicide rates. World Map showing suicide rates in all countries for which data is 1683 
available. Data from World Health Statistics, World Health Organization 2016 (Ref19).  1684 
 1685 
Figure 2. Suicide rates in selected countries from 2000–2015. 1686 
Suicide rates over the 21st century have increased in some countries (such as Brazil, Mexico and the USA) but have 1687 
decreased in others (such as China, Russia and France). Data here include both sexes combined. Data from World Health 1688 
Statistics, World Health Organization 2016 (Ref 19).  1689 
Figure 3. Suicide rates by sex from 2000-2015. 1690 
Global suicide rates stratified by sex. In general, suicide rates in males are substantially higher than in females. Data 1691 
from World Health Statistics, World Health Organization 2016 (Ref19).  1692 
 1693 
Figure 4. The biopsychosocial model of suicide risk.  1694 
The biopsychosocial model for suicide risk presents a comprehensive view of the different types of factors that may 1695 
contribute to suicide risk. The sociological, demographic and factors, as well as environmental factors, may influence any 1696 
or all of the distal, developmental and proximal factors. The external, population or society-level factors, in addition to 1697 
individual factors such as genetics, family history, personal history of abuse, behavioural dysregulation, substance abuse 1698 
and psychopathology may all interact to heighten vulnerability to suicide through behavioural disinhibition and 1699 
dysregulated mood, hopelessness and entrapment, which are in turn associated with suicidal ideation, suicide attempt 1700 
and suicide. Based data from Global suicidal ideation and suicide attempt statistics, Borges et al.338; global suicide 1701 
statistic, World Health Statistics19. 1702 
Figure 5. Neurobiological changes in suicidal behaviour. Suicidal behaviour is associated with widespread 1703 
neurobiological alterations. Of these, the alterations in the stress response pathways are among the best described in 1704 
suicidal ideation, suicidal behaviour and suicide. Disruption of the hypothalamic–pituitary–adrenal (HPA) axis affects the 1705 
coordination and signalling feedback mechanisms that control cortisol production, which is a key mediator of stress 1706 
reactivity. Long-lasting changes to HPA axis function have been documented in individuals with histories of early-life 1707 
adversity, and epigenetic processes have been identified as key mediators of those changes. The polyamine system has 1708 
been implicated in cellular responses to stress and may directly regulate mood through the antidepressant properties of 1709 
some of its constituent proteins). In addition, multiple neurotrophic a nd neurotransmission pathways, primarily in the 1710 
prefrontal cortex and the hippocampus, as well as in the raphe nuclei of the brainstem have been shown to be 1711 
dysregulated in suicidal behaviour and constitute promising targets for therapy. In addition, more-recent evidence has 1712 
suggested coordination between signalling in the brain and in the gut, potentially through immune activation.  1713 
Figure 6. Approaches for preventing suicide.  1714 
Prevention, risk assessment and diagnosis of suicidal behaviour are key to decreasing suicide rates. Prevention strategies 1715 
range from universal interventions that target the general public, selective interventions that target subpopulations with 1716 
a greater potential risk and indicated interventions that respond to individuals exhibiting suicidal ideation or suicidal 1717 
behaviour. Risk assessment approaches can occur in a variety of settings and through a variety of methods, all aiming to 1718 
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detect individuals who may be at heightened risk of suicidal behaviour to direct them to the most appropriate services. 1719 
Diagnosis involves the diagnosis of psychiatric and psychological features associated with suicidal ideation and suicidal 1720 
behaviour and includes psychopathologies and psychological traits that may contribute to suicide risk. MDD: Major 1721 
depressive disorder; BD: Bipolar disorder; ED, emergency department. 1722 
 1723 
  1724 
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Box 1. Definitions of terms commonly used in suicide research 1725 
Suicide: intentionally ending one’s own life. 1726 
Suicidal behaviour: behaviours that may result in ending one’s life, whether fatal or not. This term excludes suicidal 1727 
ideation.  1728 
Suicidal ideation: any thoughts about ending one’s own life. May be active, with a clear plan for suicide, or passive, with 1729 
thoughts about wishing to die. 1730 
Suicide attempt: self-injurious non-fatal behaviour with inferred or actual intent to die. 1731 
Self-harm: self-injurious behaviours with or without intent to die. Does not distinguish between suicide attempt and 1732 
non-suicidal self injury. 1733 
Non-suicidal self-injury: self-injurious behaviours without any intent to die.  1734 
 1735 
  1736 
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Box 2. Interventions for suicidal ideation and suicidal behaviour. 1737 
 1738 
[H1] Psychosocial 1739 
Longer-term psychosocial interventions 1740 
• Cognitive behavioural therapy 1741 
• Dialectic behavioural therapy 1742 
• Collaborative assessment and management of suicidality 1743 
• Acceptance and Commitment Therapy 1744 
• Mentalization 1745 
• Interpersonal psychotherapy 1746 
Brief interventions 1747 
• Caring contacts 1748 
• No suicide contacts 1749 
• Safety planning intervention 1750 
• Crisis response planning 1751 
• Attempted suicide short intervention programme 1752 
• Volitional helpsheet 1753 
 1754 
[H1] Pharmacological 1755 
Pharmacological agents with potential effect on suicidal behaviour 1756 
• Lithium 1757 
• Clozapinea 1758 
• Ketamine 1759 
• Selective Serotonin Reuptake Inhibitors 1760 
• Buprenorphin 1761 
aClozapine is indicated in treatment of patients with schizophrenia who present with suicidal ideation. 1762 
 1763 
1764 
  
Suicide and suicidal behaviour continue to present key challenges for public policy and health services. This Primer 
discusses the global burden of suicide and suicidal behaviours, and provides an overview of our current understanding of 
the mechanisms of suicide, including risk factors for suicidal ideation and the transition from ideation to suicide attempt. 
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